MERS virus cells


This transmission electron microscope image shows SARS-CoV-2—also known as 2019-nCoV, the virus that causes COVID-19—isolated from a patient in the U.S. Virus particles are shown emerging from the surface of cells cultured in the lab. The spikes on the outer edge of the virus particles give coronaviruses their name, crown-like.


NIAID provides research funding and resources for the scientific community to facilitate the development of vaccines, therapeutics, and diagnostics for infectious diseases, including those caused by coronaviruses.

Funding Information

Information on available funding opportunities can be found on Opportunities & Announcements. NIAID issued a Notice of Special Interest (NOSI) regarding the availability of urgent competitive revisions for research on 2019-nCoV. The NOSI highlights the urgent need for research and notes NIAID’s interest in projects focusing on viral natural history, pathogenicity, transmission, as well as projects developing medical countermeasures and suitable animal models for preclinical testing of vaccines and therapeutics against 2019-nCoV.

For more information please see NOT-AI-20-030

Resources for Researchers

NIAID provides resources to advance coronavirus research and encourage product development. These resources include viral isolates and preclinical services. Read more about tools and resources available to researchers that further coronavirus research.

Content last reviewed on